Periodontitis and erectile dysfunction can seem unrelated: one affects the tissues supporting the teeth, while the other involves the ability to develop or maintain an erection. Yet both conditions are associated with inflammation, impaired blood-vessel function, smoking, diabetes, and cardiovascular risk. Observational research has repeatedly found that men with periodontal disease are more likely to report erectile dysfunction, although the evidence does not prove that gum disease directly causes sexual dysfunction.
Periodontitis and Erectile Dysfunction: What the Evidence Shows
Periodontitis is a chronic inflammatory disease caused by a dysregulated response to bacterial communities around and below the gumline. It can produce bleeding gums, periodontal pockets, loss of connective tissue and bone, loose teeth, and eventually tooth loss. Mild gingivitis is common and reversible; periodontitis is deeper, structurally destructive disease that requires professional assessment and treatment.
Erectile dysfunction (ED) is the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual activity. Erections depend on coordinated neurologic signaling, smooth-muscle relaxation, adequate arterial inflow, restriction of venous outflow, and psychological readiness. The vascular lining, or endothelium, is particularly important because it helps regulate nitric oxide, the chemical signal that initiates relaxation of penile smooth muscle.
A 2021 systematic review and meta-analysis by Farook and colleagues combined six studies involving 215,008 participants. Periodontitis was associated with higher odds of ED (pooled odds ratio 2.56; 95% confidence interval 1.70–3.85).[1] That is a substantial association, but the studies were highly heterogeneous, with an I² of 98%. Such heterogeneity means the size of the relationship varied markedly among studies and should not be treated as a precise prediction for an individual man.
A 2022 case-control study added more clinically examined oral-health data. After adjustment for age, smoking, education, income, brushing behaviors, and gum bleeding, a higher Community Periodontal Index score was associated with greater odds of ED (adjusted odds ratio 2.755; 95% confidence interval 1.400–5.423).[2] Because the study measured exposure and outcome in a case-control framework, it still could not establish which condition came first or eliminate all confounding.
How Gum Inflammation Could Affect Erections
The leading proposed link is endothelial dysfunction. Healthy endothelium releases nitric oxide in response to neural and mechanical signals. Nitric oxide activates cyclic guanosine monophosphate, or cGMP, which reduces intracellular calcium and relaxes smooth muscle in penile arteries and erectile tissue. When endothelial signaling is impaired, arterial dilation may be weaker and the erectile response less reliable.
Periodontal inflammation does not necessarily remain confined to the mouth. Inflamed periodontal pockets can permit bacterial products and inflammatory mediators to enter the circulation. Researchers have proposed several downstream effects: increased oxidative stress, reduced nitric-oxide availability, activation of vascular inflammatory pathways, and higher concentrations of mediators such as tumor necrosis factor-alpha and C-reactive protein. These are biologically plausible connections, not proof that oral bacteria directly damage penile vessels in most patients.
The small diameter of penile arteries may also make erectile function sensitive to early vascular impairment. A modest reduction in endothelial responsiveness may become noticeable during an erection before it produces obvious symptoms in larger vessels. This is one reason persistent ED can justify evaluation of blood pressure, glucose, lipids, smoking exposure, and cardiovascular risk rather than being viewed only as a sexual-performance problem.
Shared risk factors are an equally important explanation. Smoking increases the risk of periodontal destruction and vascular ED. Diabetes impairs immune function, periodontal healing, nerves, and small blood vessels. Aging, obesity, physical inactivity, socioeconomic conditions, medication use, and inconsistent access to healthcare can influence both outcomes. Statistical adjustment reduces some of this distortion but cannot fully remove it.
Does Treating Periodontitis Improve Erectile Function?
The most direct clinical question is whether periodontal treatment changes erectile function. In a randomized controlled trial published in the Journal of Clinical Periodontology, Eltas and colleagues studied 120 men with chronic periodontitis and moderate or severe ED. Men receiving periodontal treatment had better periodontal measures, and their International Index of Erectile Function scores improved more than those of controls at three months.[3]
That result is encouraging, but it should be interpreted cautiously. It came from a single relatively small trial, erectile outcomes were questionnaire-based, and the study does not establish periodontal therapy as a standard treatment for ED. An improvement in a score may also reflect better general health, reduced discomfort, changes in confidence, or other unmeasured factors.
A 2024 systematic review of nonsurgical periodontal therapy in patients with systemic conditions included evidence involving ED and found that treatment improved periodontal outcomes.[4] Its primary purpose, however, was to assess periodontal measures such as probing depth, attachment loss, and bleeding—not to determine whether dental treatment reliably restores erections. The evidence base for sexual outcomes remains much thinner than the evidence that scaling, root planing, and oral-hygiene support improve periodontal health.
The practical conclusion is straightforward: periodontitis should be treated because untreated disease can cause irreversible tissue and tooth loss. Better erectile function may be an additional benefit for some men, but it should not be promised, and dental care should not replace a medical ED evaluation.
What Symptoms and Risk Factors Deserve Attention
Periodontitis can progress with little pain. Warning signs include gums that bleed during brushing or flossing, persistent bad breath, gum recession, increasing gaps between teeth, tooth mobility, pus at the gumline, or a change in the way the teeth meet. Bleeding is common, but it is not normal tissue behavior and warrants attention when it persists.
ED also deserves assessment when it is recurrent, worsening, or present for roughly three months or longer. Occasional difficulty during stress, fatigue, heavy alcohol use, or relationship strain is common. A continuing pattern is different, especially when erections during sleep or masturbation have also changed.
Medical review becomes more important when ED occurs alongside chest discomfort, shortness of breath with modest activity, poorly controlled blood pressure, diabetes symptoms, reduced exercise tolerance, or a strong family history of early cardiovascular disease. Urgent care is appropriate for chest pain or other symptoms suggesting an acute cardiovascular event. An erection lasting four hours or longer is also an emergency.
A clinician may review medication effects, mental health, sleep, alcohol and nicotine use, testosterone-related symptoms, blood pressure, cardiovascular fitness, and laboratory markers such as glucose or hemoglobin A1c and lipids. A dentist or periodontist can measure pocket depth, bleeding, attachment loss, and radiographic bone loss. Neither a home mirror check nor an online ED questionnaire substitutes for these examinations.
A Coordinated Approach to Oral and Sexual Health
Daily plaque control is foundational. Brush twice daily with fluoride toothpaste, clean between teeth using floss or appropriately sized interdental brushes, and follow a dental schedule based on individual risk. Established periodontitis usually requires professional debridement and may require repeated periodontal maintenance. Stopping smoking is among the most consequential steps for both periodontal prognosis and erectile vascular health.
General vascular measures matter as well. Regular aerobic and resistance exercise, adequate sleep, a dietary pattern rich in minimally processed plant foods, management of blood pressure and glucose, and moderation of alcohol may support endothelial health. These measures are not instant ED remedies, but they address risks shared by the mouth, heart, metabolic system, and penile circulation.
Men already taking an ED medication should not stop or change it because of gum disease. Phosphodiesterase type 5 inhibitors support the nitric oxide-cGMP pathway; they do not remove dental plaque or treat periodontal pockets. Conversely, periodontal care cannot correct every cause of ED, including neurologic disease, medication adverse effects, hormonal disorders, pelvic surgery, significant performance anxiety, or structural penile conditions.
Coordination is useful when both conditions are present. A dentist should know about relevant cardiovascular disease and medications, particularly anticoagulants. A prescribing clinician should know about major health changes and all medicines or supplements. Nitrate medications must not be combined with PDE5 inhibitors because blood pressure can fall dangerously. More evidence-based men's health topics are available in the health library.
Conclusion
Research supports an association between periodontitis and erectile dysfunction, with systemic inflammation, endothelial dysfunction, and shared cardiometabolic risks offering plausible explanations. The association is not the same as causation, and current data do not justify treating gum disease as a stand-alone ED therapy. Persistent bleeding gums and recurrent erectile difficulty both merit professional attention because each may reveal a broader health issue that benefits from early management.
If you're exploring clinically-formulated options, OnyxMD's Red Pill is a physician-supervised, on-demand treatment containing tadalafil and Pycnogenol; treatment plans start with a free online assessment at questionnaire.getonyxmd.com.
These statements have not been evaluated by the FDA. This content is for informational purposes only and does not constitute medical advice.
References
Farook FF, Alodwene H, Alharbi R, et al. The association between periodontitis and erectile dysfunction: a systematic review and meta-analysis. American Journal of Men's Health. 2021;15(3):15579883211007277. doi:10.1177/15579883211007277
Huang N, Li C, Sun W, Yang Y, Tang Q, Xiao F. Association between chronic periodontal disease and erectile dysfunction: a case-control study. American Journal of Men's Health. 2022;16(2):15579883221084798. doi:10.1177/15579883221084798
Eltas A, Oguz F, Uslu MO, Akdemir E. The effect of periodontal treatment in improving erectile dysfunction: a randomized controlled trial. Journal of Clinical Periodontology. 2013;40(2):148-154. doi:10.1111/jcpe.12039
Joseph P, Prabhakar P, Holtfreter B, et al. Systematic review and meta-analysis of randomized controlled trials evaluating the efficacy of non-surgical periodontal treatment in patients with concurrent systemic conditions. Clinical Oral Investigations. 2024;28(1):21. doi:10.1007/s00784-023-05392-6
Medical Disclaimer: The information provided on this website is for educational and informational purposes only and is not intended as medical advice. OnyxMD services should not be used to diagnose, treat, cure, or prevent any disease or medical condition. Always consult with a qualified healthcare provider before beginning any supplement regimen or health program.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Individual Results: Results may vary. The experiences and testimonials presented on this website are individual results that may not be typical. Your experience may be different.
Telehealth Services: OnyxMD provides telehealth services in 47 states (excluding AK, MS, NJ) through licensed healthcare providers via our partner Beluga Health, P.A. Services are subject to clinical evaluation and may not be appropriate for all individuals. Prescriptions fulfilled by Strive Pharmacy LLC (License #99-9817) and EPIQ SCRIPTS LLC.